article thumbnail

Outcomes of tricuspid valve surgery in patients with significant tricuspid regurgitation and low to intermediate risk

Heart BMJ

Background In patients with tricuspid regurgitation (TR), delayed surgical intervention is associated with poor outcomes, particularly in advanced stages. Patients were stratified using the the Tricuspid Regurgitation Impact on Outcomes (TRIO) Score (for general health risk) and TRI-SCORE (for perioperative risk).

article thumbnail

New Treatment Options Available for Patients with Tricuspid Valve Disease

DAIC

In tricuspid valve regurgitation, a complex condition that Cedars-Sinai experts regularly treat, the valve between two heart chambers on the right side doesn't open or close properly. Makkar explained the advances for patients with tricuspid valve disease in a conversationwith the Cedars-Sinai Newsroom. Image by Getty. Image by Getty.

article thumbnail

Reassessing the role of tricuspid valve surgery in the modern era

Heart BMJ

The tricuspid valve (TV), historically deemed the ’forgotten valve’, is undergoing a renaissance as mounting evidence highlights its critical role in cardiovascular outcomes.

article thumbnail

Columbia Cardiology Launches New Mitral & Tricuspid Center

DAIC

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 111
article thumbnail

First Transcatheter Tricuspid Regurgitation Treatment Approved

Med Page Today

(MedPage Today) -- The FDA approved the Evoque tricuspid valve replacement system as the first transcatheter treatment for tricuspid regurgitation (TR), Edwards Lifesciences announced. Evoque gained an indication for severe TR that is symptomatic.

Tricuspid 111
article thumbnail

Novel Tricuspid Valve Procedure Improves Patients' Quality of Life and Health Status

DAIC

milla1cf Fri, 06/21/2024 - 20:10 June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards EVOQUE system. by the Food and Drug Administration.

Tricuspid 105
article thumbnail

New Tricuspid Interventions Launched into 'Broken' System

Med Page Today

(MedPage Today) -- NEW YORK CITY -- Recent device approvals officially put transcatheter tricuspid valve intervention (TTVI) on the map for symptomatic severe tricuspid regurgitation (TR), though workforce challenges and a less-than-compelling.